NEW YORK, January 31, 2017 /PRNewswire/ --
Today's attention is directed to the Cigarettes industry which is engaged in the manufacture of cigarettes, cigars, smoking and chewing tobacco, and other tobacco products such as snuff and bidis. Challenges faced by industry operators include increased awareness of health risks, stricter regulation, and higher taxes. Pre-market, Stock-Callers.com has issued research reports on these four stocks: Reynolds American Inc. (NYSE: RAI), Altria Group Inc. (NYSE: MO), Philip Morris International Inc. (NYSE: PM), and British American Tobacco PLC (NYSE MKT: BTI). Learn more about these stocks by accessing their free research reports at:
On Monday, Winston-Salem, North Carolina headquartered Reynolds American Inc.'s stock recorded a trading volume of 4.98 million shares, and ended the day at $59.87, declining 0.78% from the last trading session. The Company's shares have advanced 7.03% in the last one month, 11.26% over the previous three months, and 6.83% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 7.37% and 17.20%, respectively. Furthermore, shares of Reynolds American, which through its subsidiaries, manufactures, and sells cigarettes and other tobacco products in the US, have a Relative Strength Index (RSI) of 77.14.
On January 17th, 2017, Reynolds American announced that British American Tobacco will acquire the 57.8% of Reynolds American's common stock that it does not currently own for $29.44 per share in cash and a number of British American Tobacco American depositary shares representing 0.5260 of a British American Tobacco's ordinary share, currently worth $30.20 per share based on the British American Tobacco closing share price as of January 16th, 2017, and the corresponding Dollar-Sterling exchange rate.
On January 18th, 2017, research firm Citigroup downgraded the Company's stock rating from 'Buy' to 'Neutral'. Free research report on RAI is available at:
Richmond, Virginia headquartered Altria Group Inc.'s stock rose 0.38%, finishing yesterday's session at $71.30. A total volume of 8.57 million shares was traded, which was above their three months average volume of 6.75 million shares. The Company's shares have gained 5.61% in the last month, 11.67% over the previous three months, and 5.44% since the start of this year. The stock is trading above its 50-day and 200-day moving averages by 7.36% and 10.60%, respectively. Additionally, shares of Altria Group, which through its subsidiaries, manufactures and sells cigarettes, smokeless products, and wine in the US, have an RSI of 79.20.
On January 04th, 2017, research firm Bank of America/ Merrill upgraded the Company's stock rating from 'Neutral' to 'Buy'.
On January 17th, 2017, Altria Group announced that it has acquired the privately-held Sherman Group Holdings, LLC and its subsidiaries (Nat Sherman). Nat Sherman sells super-premium cigarettes and premium cigars, and joins Philip Morris USA Inc. and John Middleton Co. as part of Altria's smokeable products segment. Terms of the transaction were not disclosed. The complimentary research report on MO can be downloaded at:
Shares in New York-based Philip Morris International Inc. ended Monday's session 0.37% lower at $95.96. The stock recorded a trading volume of 3.40 million shares. The Company's shares have gained 5.52% in the past one month, 1.34% in the previous three months, and 4.89% since the start of this year. The stock is trading 6.01% above its 50-day moving average and 0.78% above its 200-day moving average. Moreover, shares of Philip Morris International, which through its subsidiaries, manufactures and sells cigarettes, other tobacco products, and other nicotine-containing products, have an RSI of 70.56.
On January 04th, 2017, research firm Bank of America/ Merrill downgraded the Company's stock rating from 'Buy' to 'Neutral', with a target price of $96 per share.
On January 26th, 2017, Philip Morris International announced that it will host a live audio webcast on February 02nd, 2017, at 9:00 a.m. ET to discuss its Q4 2016 and full-year 2016 results, which will be issued at approximately 7:00 a.m. ET the same day. Visit us today and access our complete research report on PM at:
British American Tobacco
At the close of trading on Monday, London, UK headquartered British American Tobacco PLC's stock dropped 1.32%, finishing at $121.99. A total volume of 1.64 million shares was traded. The Company's shares have advanced 9.54% in the last month, 8.84% over the previous three months, and 8.27% on an YTD basis. The stock is trading 8.38% and 1.97% above its 50-day and 200-day moving averages, respectively. Additionally, shares of British American Tobacco, which engages in the production and sale of tobacco products, have an RSI of 70.75. Get free access to your research report on BTI at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA